Biochemistry · Water & Electrolytes
Potassium (K⁺) is the primary intracellular cation, essential for maintaining cellular membrane potential, enzyme function, and acid-base balance. The body tightly regulates potassium levels through renal excretion, gastrointestinal absorption, and transcellular shifts. Dysregulation can lead to life-threatening arrhythmias or neuromuscular dysfunction, making understanding its metabolism critical for clinical practice.
Potassium plays a pivotal role in excitable tissues, such as nerves and muscles, by establishing the resting membrane potential. It is also a cofactor for enzymes involved in glycolysis and protein synthesis. The Na⁺/K⁺-ATPase pump actively maintains the steep potassium gradient across cell membranes, with intracellular concentrations (~140 mEq/L) far exceeding extracellular levels (~3.5–5.0 mEq/L).
The kidneys are the primary regulators of potassium homeostasis, excreting ~90% of daily intake. Potassium is freely filtered at the glomerulus, with reabsorption occurring in the proximal tubule and thick ascending limb of the loop of Henle. The distal convoluted tubule and collecting duct fine-tune excretion via principal cells, which secrete K⁺ under the influence of aldosterone, and intercalated cells, which reabsorb K⁺ in states of deficiency. Factors such as tubular flow rate, sodium delivery, and pH also modulate potassium handling.
Aldosterone is the key hormone regulating potassium excretion, acting on mineralocorticoid receptors in the distal nephron to increase Na⁺ reabsorption and K⁺ secretion. Insulin and catecholamines promote cellular uptake of potassium via Na⁺/K⁺-ATPase activation, while acid-base disturbances alter potassium distribution; acidosis shifts K⁺ out of cells, and alkalosis shifts it inward. These mechanisms ensure rapid adaptation to dietary intake or pathological losses.
Transcellular shifts of potassium between intracellular and extracellular compartments occur in response to metabolic demands. Insulin, for example, drives potassium into cells by stimulating Na⁺/K⁺-ATPase, a mechanism exploited clinically to treat hyperkalemia. Exercise-induced potassium release from muscle cells enhances local blood flow, while cell lysis (e.g., rhabdomyolysis) can cause dangerous hyperkalemia. These shifts are critical for maintaining serum potassium within a narrow range despite variable intake.
Hypokalemia (<3.5 mEq/L) arises from renal losses (e.g., diuretics, hyperaldosteronism), gastrointestinal losses (e.g., diarrhea), or transcellular shifts (e.g., alkalosis, insulin therapy). Symptoms include muscle weakness, cramps, and cardiac arrhythmias, such as U waves on ECG. Hyperkalemia (>5.0 mEq/L) results from impaired renal excretion (e.g., renal failure, hypoaldosteronism), cell lysis, or acidosis. Severe hyperkalemia can cause peaked T waves, widened QRS complexes, and ventricular fibrillation.
Diagnosis of potassium disorders involves serum electrolyte measurement, ECG evaluation, and assessment of acid-base status. Treatment of hypokalemia includes oral or intravenous potassium supplementation, while hyperkalemia management prioritizes cardiac stabilization (e.g., calcium gluconate), potassium redistribution (e.g., insulin/glucose, β-agonists), and removal (e.g., diuretics, dialysis). Underlying causes, such as medication adjustments or endocrine disorders, must be addressed to prevent recurrence.
Potassium is critical for cellular function, with tight regulation achieved through renal excretion, hormonal control, and transcellular shifts. The kidneys, particularly the distal nephron, play a central role in maintaining potassium balance under the influence of aldosterone. Dysregulation leads to hypokalemia or hyperkalemia, both of which have significant cardiovascular and neuromuscular consequences.
Potassium disorders are common in clinical practice, often secondary to medications (e.g., diuretics, ACE inhibitors), renal disease, or endocrine abnormalities. Recognizing ECG changes, such as U waves in hypokalemia or peaked T waves in hyperkalemia, is essential for timely intervention. Management requires addressing both the acute disturbance and underlying etiology to restore homeostasis.
Potassium metabolism is intricately linked to acid-base status; acidosis promotes hyperkalemia by shifting potassium out of cells, while alkalosis has the opposite effect. This relationship is exploited therapeutically, such as using bicarbonate to treat hyperkalemia. Understanding these interactions is crucial for managing complex electrolyte disturbances in critically ill patients.